{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:06:12Z","timestamp":1760015172611,"version":"3.34.0"},"reference-count":16,"publisher":"Georg Thieme Verlag KG","issue":"04","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dtsch Med Wochenschr"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1055\/a-2382-6433","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T23:30:26Z","timestamp":1738193426000},"page":"167-172","source":"Crossref","is-referenced-by-count":1,"title":["Atypisches h\u00e4molytisch-ur\u00e4misches Syndrom: Differentialdiagnostik und Therapie"],"prefix":"10.1055","volume":"150","author":[{"given":"Anja","family":"G\u00e4ckler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul Thomas","family":"Brinkk\u00f6tter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"issue":"02","key":"ref1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ckj\/sfz066","article-title":"Relative incidence of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome in clinically suspected cases of thrombotic microangiopathy","volume":"13","author":"U Sch\u00f6nermarck","year":"2019","journal-title":"Clin Kidney J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2147\/CLEP.S245642","article-title":"Epidemiology of atypical hemolytic uremic syndrome: a systemic literature review","volume":"12","author":"K Yan","year":"2020","journal-title":"Clin Epidemiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome","volume":"390","author":"F Fakhouri","year":"2017","journal-title":"Lancet"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1111\/trf.13654","article-title":"Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study","volume":"56","author":"A Li","year":"2016","journal-title":"Transfusion"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults","volume":"8","author":"V Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40620-016-0288-3","article-title":"Improved renal recovery in patients with atypical hemolytic uremic syndrome following rapid initiation of eculizumab treatment","volume":"30","author":"J Walle","year":"2017","journal-title":"J Nephrol"},{"issue":"01","key":"ref7","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12882-017-0727-y","article-title":"Differential diagnosis of thrombotic microangiopathy in nephrology","volume":"18","author":"T Jokiranta","year":"2017","journal-title":"BMC Nephrol"},{"issue":"19","key":"ref8","first-page":"327","article-title":"Differenzialdiagnose und Therapie thrombotischer Mikroangiopathien","volume":"115","author":"M Bommer","year":"2018","journal-title":"Dtsch Arztebl Int"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S2352-3026(17)30026-1","article-title":"Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study","volume":"4","author":"P Bendapudi","year":"2017","journal-title":"Lancet Haematol"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"e10208","DOI":"10.1371\/journal.pone.0010208","article-title":"Predictive features of severe acquired ADAMTS13 deficiency in idiopathic thrombotic microangiopathies: the French TMA reference center experience","volume":"5","author":"P Coppo","year":"2010","journal-title":"PLoS One"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ekir.2021.11.009","article-title":"Proteinuria increases the PLASMIC and French Scores performance to predict thrombotic thrombocytopenic purpura in patients with thrombotic microangiopathy syndrome","volume":"7","author":"N Fage","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"23","key":"ref13","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"C Legendre","year":"2013","journal-title":"N Engl J Med"},{"issue":"03","key":"ref14","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.kint.2015.11.026","article-title":"Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome","volume":"89","author":"L Greenbaum","year":"2016","journal-title":"Kidney Int"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.kint.2020.01.035","article-title":"The long-acting C5 inhibitor, ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naive to complement inhibitor treatment","volume":"97","author":"E Rondeau","year":"2020","journal-title":"Kidney Int"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00467-020-04774-2","article-title":"The long-acting C5 inhibitor, ravulizumab, is efficacious and safe in pediatric patients with atypical hemolytic uremic syndrome previously treated with eculizumab","volume":"36","author":"K Tanaka","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11560-019-0357-4","article-title":"Charakterisierung von Patienten mit atypischem h\u00e4molytisch-ur\u00e4mischen Syndrom (aHUS) in Deutschland, Daten aus dem globalen aHUS-Register","volume":"14","author":"C Haas","year":"2019","journal-title":"Nephrologe"}],"container-title":["DMW - Deutsche Medizinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2382-6433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T23:30:53Z","timestamp":1738193453000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2382-6433"}},"subtitle":["Ein Diagnose- und Behandlungsleitfaden f\u00fcr die Praxis"],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":16,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2025,1,29]]},"published-print":{"date-parts":[[2025,2]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2382-6433","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0012-0472","1439-4413"],"issn-type":[{"value":"0012-0472","type":"print"},{"value":"1439-4413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]}}}